Relpax and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include blister infected among females.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Gaviscon. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.



On Jul, 19, 2026

11 people who take Relpax and Gaviscon together, and have interactions are studied.

Relpax and Gaviscon drug interactions.

What are the common drug interactions of Relpax and Gaviscon, by gender? *:

female:

  1. Blister infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Chronic kidney disease
  3. Alopecia (absence of hair from areas of the body)
  4. Arthralgia (joint pain)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Asthenia (weakness)
  7. Asthma
  8. Cough
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Injection site infection

male:

n/a

What are the common drug interactions of Relpax and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Asthenia (weakness)
  4. Laryngeal oedema (swelling of larynx)
  5. Myalgia (muscle pain)
  6. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  7. Polyarthritis (arthritis which involves 5 or more joints simultaneously)
  8. Rash papular (redness with papule)
  9. Tongue oedema (swelling of tongue)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal injury (kidney injury)
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)

60+:

  1. Blister infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Infusion site ulcer
  3. Cough
  4. Injection site infection
  5. Infusion site vesicles (fluid- or air-filled cavity or sac at infusion site)
  6. Ingrowing nail
  7. Purulent discharge (discharge that contains pus)
  8. Scar
  9. Wound secretion
  10. Ulcer

What are the existing conditions these people have? *

  1. Pain: 6 people, 54.55%
  2. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 54.55%
  3. Asthma: 6 people, 54.55%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 9.09%
  5. Abdominal Pain Upper: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Relpax and Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relpax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gaviscon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide and aluminum hydroxide; magnesium trisilicate (the active ingredients of Relpax and Gaviscon, respectively), and Relpax and Gaviscon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: